Search Orphan Drug Designations and Approvals
-
Generic Name: | (1'R,6'R)-3-(Benzylamine)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione |
---|---|
Date Designated: | 07/06/2017 |
Orphan Designation: | Treatment of systemic scleroderma (SSc) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Emerald Health Pharmaceuticals Inc. 5820 Nancy Ridge Drive San Diego, California 92121 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-